These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8628415)

  • 21. [Screening for colorectal cancer: importance of fecal occult blood test].
    De Paula AO
    Acta Gastroenterol Latinoam; 1999; 29(2):79-81. PubMed ID: 10491720
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunologic detection of fecal occult blood from upper digestive tract diseases.
    Nakama H; Kamijo N; Fattah AS; Zhang B
    Hepatogastroenterology; 1998; 45(21):752-4. PubMed ID: 9684127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-office fecal occult blood tests fail to detect cancer.
    Health News; 2005 May; 11(5):8. PubMed ID: 15884165
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
    Allison JE
    N Engl J Med; 2001 Mar; 344(13):1022; author reply 1023. PubMed ID: 11280326
    [No Abstract]   [Full Text] [Related]  

  • 25. [Early detection of colon carcinomas. Diagnostic series: fecal occult blood].
    Janssen K
    MMW Fortschr Med; 2000 Nov; 142(46):46. PubMed ID: 11132313
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Fletcher RH; Ransohoff DF; Imperiale TF
    Cancer; 2007 May; 109(9):1925-6; author reply 1926. PubMed ID: 17370313
    [No Abstract]   [Full Text] [Related]  

  • 27. Should all people over the age of 50 have regular fecal occult-blood tests? Postpone population screening until problems are solved.
    Simon JB
    N Engl J Med; 1998 Apr; 338(16):1151-2; discussion 1154-5. PubMed ID: 9545367
    [No Abstract]   [Full Text] [Related]  

  • 28. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of diverticulosis coli and vascular ectasias and the results of fecal occult blood test.
    Nakama H; Fattah AS; Zhang B; Kamijo N; Uehara Y
    Hepatogastroenterology; 2000; 47(35):1277-9. PubMed ID: 11100332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal blood loss as an aggravating factor of iron deficiency in infants aged 9 to 12 months fed whole cow's milk.
    Fernandes SM; de Morais MB; Amancio OM
    J Clin Gastroenterol; 2008 Feb; 42(2):152-6. PubMed ID: 18209584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal-occult-blood test screening for colorectal cancer.
    Zacks M
    J Fam Pract; 1997 Mar; 44(3):247-8. PubMed ID: 9071239
    [No Abstract]   [Full Text] [Related]  

  • 32. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of upper gastrointestinal blood with fecal occult blood tests.
    Rockey DC; Auslander A; Greenberg PD
    Am J Gastroenterol; 1999 Feb; 94(2):344-50. PubMed ID: 10022627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New criteria for detecting occult hemorrhage in screening for colorectal cancer].
    Ottó S
    Orv Hetil; 2001 Jul; 142(29):1541-5. PubMed ID: 11494745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colon Cancer Screening Guidelines 2005: the fecal occult blood test option has become a better FIT.
    Allison JE
    Gastroenterology; 2005 Aug; 129(2):745-8. PubMed ID: 16083728
    [No Abstract]   [Full Text] [Related]  

  • 37. Digital rectal fecal occult blood screening during gynecologic examination.
    Willis FL; Fanning J
    Am J Obstet Gynecol; 2004 May; 190(5):1422-3. PubMed ID: 15167856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a desk top instrument for the automated development and immunochemical quantification of fecal occult blood.
    Rozen P; Waked A; Vilkin A; Levi Z; Niv Y
    Med Sci Monit; 2006 Jun; 12(6):MT27-32. PubMed ID: 16733493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid fecal cytokeratin-19 test and fecal occult blood test in screening for gastrointestinal diseases.
    Kim H; Kim Y; Yoon S; Lim J; Kim M; Lee S; Kang S; Lee EJ; Kang CS; Han K
    Ann Clin Lab Sci; 2006; 36(3):294-8. PubMed ID: 16951270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.